NCT01623479View on ClinicalTrials.gov

An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

CompletedOBSERVATIONAL

Enrollment

585

Participants

Timeline

Start Date

November 19, 2010

Primary Completion Date

September 1, 2011

Study Completion Date

September 1, 2011

Conditions

Eyelash Hypotrichosis

Interventions

DRUG

bimatoprost 0.03%

Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months

Trial Locations (1)

Unknown

Santa Ana

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY